{"nct_id":"NCT05578976","title":"A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2023-02-08","start_date_type":"ACTUAL","primary_completion_date":"2027-06","primary_completion_date_type":"ESTIMATED","completion_date":"2029-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GMAB"]}